| Patricia L Seymour, MD | |
|
119 Belmont St, Hospital Medicine, Worcester, MA 01605 | |
| (503) 334-5571 | |
| Not Available |
| Full Name | Patricia L Seymour |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 119 Belmont St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023216934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 245794 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
A wide range of fetal genetic abnormalities could soon be detected in early pregnancy thanks to a world-first study led by University of South Australia researchers using lab-on-a-chip, non-invasive technology.
Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
Women who consume alcohol during pregnancy -; even in small amounts -; have a 19% greater risk of miscarriage than women who don't use alcohol, according to a new study by Vanderbilt researchers.
Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD (recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
A wide range of fetal genetic abnormalities could soon be detected in early pregnancy thanks to a world-first study led by University of South Australia researchers using lab-on-a-chip, non-invasive technology.
Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
Women who consume alcohol during pregnancy -; even in small amounts -; have a 19% greater risk of miscarriage than women who don't use alcohol, according to a new study by Vanderbilt researchers.
Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD (recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia L Seymour, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Patricia L Seymour, MD 119 Belmont St, Hospital Medicine, Worcester, MA 01605 Ph: (503) 334-5571 |
News Archive
A wide range of fetal genetic abnormalities could soon be detected in early pregnancy thanks to a world-first study led by University of South Australia researchers using lab-on-a-chip, non-invasive technology.
Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
Women who consume alcohol during pregnancy -; even in small amounts -; have a 19% greater risk of miscarriage than women who don't use alcohol, according to a new study by Vanderbilt researchers.
Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD (recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
› Verified 8 days ago
Dr. Pankaj Anil Ksheersagar, M.B.B.S.,M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-5571 | |
Parveen Gill, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Med Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 | |
Rajiv Balasuriya, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Medical Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 | |
Lori Dilorenzo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Mechanic St, Attn: Damaris Diaz, Worcester, MA 01608 Phone: 508-792-5400 Fax: 508-831-0074 | |
Dr. Lee A Mancini, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5812 | |
Mrs. Isabella Anna Richard, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 926 Southbridge St Apt 17, Worcester, MA 01610 Phone: 508-353-4611 |